Date published: 2025-10-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

Temozolomide-d3 (CAS 208107-14-6)

0.0(0)
Write a reviewAsk a question

Application:
Temozolomide-d3 is a labeled antineoplastic chemical
CAS Number:
208107-14-6
Molecular Weight:
197.17
Molecular Formula:
C6H3D3N6O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Temozolomide-d3 is a deuterated analog of Temozolomide that is used in the field of analytical chemistry, particularly in the development of mass spectrometric methods. Its incorporation of three deuterium atoms makes it a suitable internal standard for quantifying Temozolomide through mass spectrometry, due to the minimal difference in chemical behavior compared to the non-deuterated form while providing a distinct mass difference. Research involving Temozolomide-d3 often focuses on the optimization of detection methods for Temozolomide, ensuring accurate and precise measurement of the compound in complex biological matrices. The use of Temozolomide-d3 also extends to studies on the kinetics and metabolic fate of Temozolomide, where it can be used to track the absorption, distribution, metabolism, and excretion of the compound. Furthermore, it is instrumental in the calibration of instruments and validation of analytical procedures, which are critical for ensuring the reliability of data in research applications.


Temozolomide-d3 (CAS 208107-14-6) References

  1. A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions.  |  Muggeri, A., et al. 2017. Drugs R D. 17: 427-434. PMID: 28756607
  2. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish.  |  Yan, C., et al. 2019. Cell. 177: 1903-1914.e14. PMID: 31031007
  3. Bioequivalence study of 20-mg and 100-mg temozolomide capsules (TOZ309 and Temodal®) in glioma patients in China.  |  Hu, C., et al. 2020. Cancer Chemother Pharmacol. 86: 793-801. PMID: 33089408

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Temozolomide-d3, 1 mg

sc-212996
1 mg
$300.00